rhodamine b has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Gang, Y; Huang, N; Lin, A; Liu, J; Liu, Y; Long, L | 1 |
| Anantharaju, KS; Daruka Prasad, B; Lingaraju, K; Malleshappa, J; Nagabhushana, H; Prashantha, SC; Raja Naika, H; Sharma, SC; Surendra, BS; Vidya, YS | 1 |
2 other study(ies) available for rhodamine b and Escherichia coli Infections
| Article | Year |
|---|---|
Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Membrane; Drug Carriers; Drug Compounding; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Folic Acid; Genes, MDR; Hydrogen-Ion Concentration; Mice; Nanoparticles; Rhodamines; Silicon Dioxide; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Static Electricity; Wound Healing | 2018 |
Leucas aspera mediated multifunctional CeO2 nanoparticles: Structural, photoluminescent, photocatalytic and antibacterial properties.
Topics: Anti-Bacterial Agents; Catalysis; Cerium; Escherichia coli; Escherichia coli Infections; Fluorescent Dyes; Humans; Lamiaceae; Light; Luminescence; Nanoparticles; Particle Size; Photolysis; Plant Extracts; Rhodamines; Staphylococcal Infections; Staphylococcus aureus | 2015 |